共 50 条
- [4] PHARMACOKINETICS (PK) OF IV AND PO MYCOPHENOLATE MOFETIL (MMF) IN AGE ADJUSTED PEDIATRIC AND ADOLESCENT ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS: SIGNIFICANTLY HIGHER CLss AND Vss IN PATIENTS <6 YEARS OF AGE [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 132 - 133
- [8] Mycophenolate mofetil (MMF)/tacrolimus (FK506) is an effective and safe regimen for graft versus host disease (GVHD) prophylaxis in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) and association with acute GVHD [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 528A - 528A